SPONSOR
Beijing Tongren Hospital
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 4
Conditions studied: Macular DegenerationAnti-N-Methyl-D-Aspartate Receptor EncephalitisMarginal Zone Lymphoma(MZL)
NCT05445063 Phase 1
Recruiting
Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
Macular Degeneration
NCT06510283 Phase 2
Recruiting
Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
NCT07355699 Phase 4
Recruiting
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Marginal Zone Lymphoma(MZL)